SEARCH RESULTS

340307 RESULTS

SHR-1707

THERAPEUTICS Immunotherapy (passive) Amyloid-Related Two Phase 1 studies, in China and Australia, assessed safety and pharmacokinetics of SHR-1701 in healthy participants (Yang et al., 2024). In China, 50 young adults in five cohorts received 2, 6, 20, 40, or 60 mg/kg

Current Filters

No filters selected

Filter By

DATE RANGE
  • All
  • Past 7 Days
  • Past 30 Days
  • Past 90 Days
  • Past 12 Months
  • Specific Dates
    1. From
      To

TYPE